Keap1 Cystenine 151 as a Potential Target for Artemisitene-Induced Nrf2 Activation

Biomed Res Int. 2019 Oct 15:2019:5198138. doi: 10.1155/2019/5198138. eCollection 2019.

Abstract

Artemisitene (ATT) activates the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) by increasing its stabilization and reducing ubiquitination. The cysteine (Cys) residues of the cytosolic Nrf2 repressor Kelch-like ECH-associated protein-1 (Keap1) function as redox sensors and may be crucial in activating Nrf2. To determine whether ATT-induced Nrf2 activation is dependent on the modification of Keap1 and to elucidate the underlying mechanism, we transfected cell lines with six different Keap1 mutant constructs, each with a Cys (-77, -151, -257, -273, -288, and -297) to Ser substitution. Only the Cys151Ser mutant prevented ATT-mediated activation of Nrf2, indicating that the Cys151 residue of Keap1 likely interacts with ATT and is essential for Nrf2 stabilization and transcription of downstream genes. Our finding provides a pharmacological basis for using artemisitene against oxidative stress-related diseases.

MeSH terms

  • A549 Cells
  • Amino Acid Substitution / genetics
  • Artemisinins / pharmacology*
  • Cysteine / genetics
  • Humans
  • Kelch-Like ECH-Associated Protein 1 / genetics*
  • Mutant Proteins / genetics*
  • NF-E2-Related Factor 2 / genetics*
  • Oxidation-Reduction
  • Serine / genetics
  • Transcriptional Activation / genetics
  • Ubiquitination

Substances

  • Artemisinins
  • Kelch-Like ECH-Associated Protein 1
  • Mutant Proteins
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • artemisitene
  • Serine
  • Cysteine